〔1〕Guo S Q,Zhang Y Z. Overexpression of enhancer of zests
homolog 2 in lymphoma〔J〕. Chin Med J(Engl),2012,125
(20): 3735-3739.
〔2〕Yu J,Rhodes D R,Tomlins S A,et al. A polycomb repres?
sion signature in metastatic prostate cancer predicts cancer
outcome〔J〕. Cancer Res,2007,67(22):10657-10663.
〔3〕Bracken A P,Pasini D,Capra M,et al. EZH2 is downstream
of the pRB-E2F pathway,essential for proliferation and am?
plified in cancer〔J〕. EMBO J,2003,22(20):5323-5335.
〔4〕Varambally S,Dhanasekaran S M,Zhou M,et al. The poly?
comb group protein EZH2 is involved in progression of pros?
tate cancer〔J〕. Nature,2002,419(6907):624-629.
〔5〕Chase A,Cross N C. Aberrations of EZH2 in cancer〔J〕.
Clin Cancer Res,2011,17(9):2613-2618.
〔6〕Chen J,Li J,Han Q,et al. Enhancer of zeste homolog 2 is
overexpressed and contributes to epigenetic inactivation of
p21 and phosphatase and tensin homolog in B-cell acute
lymphoblastic leukemia〔J〕. Exp Biol Med(Maywood),2012,
237(9): 1110-1116.
〔7〕Zhou, Z. Strong expression of EZH2 and accumulation of tri?
methylated H3K27 in diffuse large B-cell lymphoma inde?
pendent of cell of origin and EZH2 codon 641 mutation〔DB/
OL〕.(2015-03-08)〔2015-05-21〕. http://www.tandfonline.
com/doi/full/10.3109/10428194.2015.1006220.
〔8〕Kanduri M,Sander B,Ntoufa S,et al. A key role for EZH2
in epigenetic silencing of HOX genes in mantle cell lympho?
ma〔J〕. Epigenetics,2013,8(12):1280-1288.
〔9〕Zhang P,Garnett J,Creighton C J,et al. EZH2-miR-30d-
KPNB1 pathway regulatesmalignantperipheral nerve sheath
tumour cell survival and tumourigenesis〔J〕. J Pathol,2014,
232(3):308-318.
〔10〕王晓雪,王光明,丁跃明,等. EZH2 与神经胶质瘤的现
况研究〔J〕. 中华临床医师杂志,2013,7(24):11695-
11687.